The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease

PHASE3UnknownINTERVENTIONAL
Enrollment

1,508

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

December 31, 2012

Conditions
Chronic Kidney Disease
Interventions
DRUG

Sulodexide

SLX 500 LRU, SLX 1000 LRU, SLX 2000 LRU per day to be taken orally for 12 months.

DRUG

placebo capsules

8 soft-gel capsules per day to be taken orally for 12 months

Trial Locations (7)

Unknown

Mary Mediatrix Medical Center, Lipa City

Rizal Private Clinics, Metro Manila

Holy Child Hospital, Dumaguete

Victoriano R. Potenciano Medical Center, Mandaluyong

Metropolitan Medical Center, Manila

Manila Adventist Medical Center, Pasay

The Medical City, Pasig

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alfasigma S.p.A.

INDUSTRY

lead

Corbridge Group Philippines, Inc.

OTHER